Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Women and their families are encouraged to come along to a public open day, on Tuesday 24th May, about research into the health of women and babies. During the event you can listen to talks and meet the teams who are involved in gynaecology, pregnancy and reproduction research.

OSPREA (Oxford Safer Pregnancy Alliance) is a team of doctors, scientists, researchers, midwives, nurses and support staff who are working together with women and their families to carry out research relating to pregnancy and reproduction.  Along with Gynaecology research colleagues they will be hosting a free open day for the public to come along and find out more about the range of research and the latest findings into women's reproductive health.

The event runs from 12.00 - 16.000 and refreshments will be available. Presentations will cover both obstetrics and gynaecology research studies as well as the experiences of research participants.  For more detailed information about the event programme visit www.osprea.ox.ac.uk

All are welcome and if you would like to attend, please register your interest at: enquiries@obs-gyn.ox.ac.uk  or, you can also drop in on the day.  

About OSPREA: The OSPREA Research Unit is a dedicated centre based in the John Radcliffe Hospital, Oxford, staffed by an experienced team of research midwives and doctors. We are primarily supported by the Nuffield Department of Obstetrics and Gynaecology, part of the University of Oxford, the Oxford University Hospitals NHS Foundation Trust and the Thames Valley CRN, part of the National Institute for Health Research.

The Oxford Safer Pregnancy  Alliance

Similar stories

New Professor of Obstetrics Title

Enormous well done to our new Professor Sally Collins - she was conferred the title of Professor of Obstetrics by the University's Medical Sciences Division Board.

INTERCOVID Study cited in the New Yorker

Fantastic news for our team who have been working on the INTERCOVID Study, which launched in April 2020. This week on 12th August 2022, the research findings cited in the New Yorker! This work was a combined effort from 43 institutions in 18 countries and involved more than two thousand pregnant women.

Women's Health Strategy for England Launched

The government has published the first ever Women's Health Strategy for England to tackle the gender health gap. Menopause, Endometriosis, Contraception and Fertility treatment are highlighted as some of the top issues women have asked for action on. The Nuffield Department of Women's & Reproductive Health welcome and fully support this bold and exciting strategy to help improve the health of millions of women in England.

Pregnancy is more likely with urine tests and timed intercourse

Dr Tatjana Gibbons leads study that suggests a woman's chance of conceiving is improved by using urine tests to detect the optimum time for intercourse, but further research is still needed to assess whether timed intercourse via any ovulation detection method creates a difference in live births and pregnancy rates.

Prof Christian Becker wins Clinical Science Award at ESHRE 2022

Congratulations to Professor Christian Becker who was presented with a Clinical Science Award for best oral presentation at the ESHRE 38th Annual Meeting in Milan, Italy this week.

Oxford's largest ever study into Varicose veins shows need for surgery is linked to genetics

Varicose veins are a very common manifestation of chronic venous disease, affecting over 30% of the population in Western countries. In America, chronic venous disease affects over 11 million men and 22 million women aged 40–80 years old. Left untreated it can escalate to multiple health complications including leg ulcers and ultimately amputations. A new international study by Oxford researchers published on 2nd June 2022 in Nature Communications establishes for the first time, a critical genetic risk score to predict the likelihood of patients suffering with Varicose veins to require surgery, as well as pointing the way towards potential new therapies.